1-19 of 19
MF Press
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PD3-11: HER2/ERBB2 status in “HER2 equivocal” breast cancers by FISH and ASCO-CAP guidelines: False-positives due to heterozygous deletions of alternative control loci

MF Press, JA Seoane, C Curtis, E Quinaux, R Guzman, G Sauter, W Eiermann, JR Mackey, N Robert, T Pienkowski, J Crown, M Martin, V Valero, V Bee, Y Ma, I Villalobos, DJ Slamon
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): PD3-11.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-PD3-11
Published: 15 February 2019
View article
Journal Articles

Abstract P3-06-01: Clonal evolution and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

JL Caswell-Jin, K McNamara, JG Reiter, R Sun, Z Hu, Z Ma, CJ Suarez, S Tilk, A Raghavendra, V Forte, S-F Chin, H Bardwell, E Provenzano, C Caldas, J Lang, R West, D Tripathy, MF Press, C Curtis
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P3-06-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-P3-06-01
Published: 15 February 2019
View article
Journal Articles

Abstract PD3-06: Association of intrinsic subtypes with pathological complete response (pCR) in the KRISTINE neoadjuvant phase 3 clinical trial in HER2-positive early breast cancer (EBC)

A Prat, D Slamon, SA Hurvitz, MF Press, G Lewis Phillips, V Lopez Valverde, A Kiermaier, H-J Helms, M Martin, SL de Haas
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): PD3-06.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-PD3-06
Published: 15 February 2018
View article
Journal Articles

Abstract PD5-01: Final results of NeoMONARCH: A phase 2 neoadjuvant study of abemaciclib in postmenopausal women with hormone receptor positive (HR+), HER2 negative breast cancer (BC)

M Martin, SA Hurvitz, D Chan, M Fernandez-Abad, E Petru, R Rostorfer, V Guarneri, C-S Huang, MF Press, TM Costigan, CW Caldwell, S Wijayawardana, PK Turner, S Barriga, DJ Slamon
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): PD5-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-PD5-01
Published: 15 February 2018
View article
Journal Articles

Abstract P6-07-09: Biomarker analysis from the neoadjuvant KRISTINE study in HER2-positive early breast cancer (EBC)

SL de Haas, SA Hurvitz, M Martin, A Kiermaier, G Lewis Phillips, J Xu, H-J Helms, D Slamon, MF Press
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P6-07-09.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P6-07-09
Published: 15 February 2017
View article
Journal Articles

Abstract P1-03-03: High concordance of ER, PR, HER2 and Ki67 by central IHC and FISH with mRNA measurements by GeneXpert® breast cancer stratifier assay

NC Wu, W Wong, KE Ho, VC Chu, A Rizo, S Davonport, D Kelly, R Makar, J Jassem, R Duchnowska, W Biernat, B Radecka, T Fujita, JL Klein, M Stonecypher, S Ohta, H Juhl, JM Weidler, M Bates, MF Press
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P1-03-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P1-03-03
Published: 15 February 2017
View article
Journal Articles

Abstract P1-03-09: Highly reproducible decentralized gene expression analysis of ESR1, PGR, ERBB2 and MKi67 on an automated, standardized molecular diagnostics platform, GeneXpert

W Wong, KE Ho, N Wu, VC Chu, P Lalli, JW Longshore, J Klein, M Stonecypher, C Lykke, T Sherwood, S Davenport, J Weidler, M Bates, MF Press
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P1-03-09.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P1-03-09
Published: 15 February 2017
View article
Journal Articles

Abstract P4-12-07: CCND1 amplification in early breast cancer patients: Correlation with subtypes and prognosis

DC Hanf, PA Fasching, IE Villalobos, A Gasparyan, D Wachter, A Santiago, R Guzman, S Weihbrecht, V Hanf, A Hartmann, MW Beckmann, MF Press
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P4-12-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P4-12-07
Published: 15 February 2017
View article
Journal Articles

Abstract P2-08-16: Prognostic and predictive abilities of intrinsic subtype in hormone receptor-positive metastatic breast cancer from the EGF30008 phase III clinical trial

A Prat, MCU Cheang, P Galván, P Nuciforo, L Paré, B Adamo, M Viladot, MF Press, R Gagnon, C Ellis, S Johnston
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P2-08-16.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P2-08-16
Published: 15 February 2016
View article
Journal Articles

Abstract P3-07-08: Quantitative HER family proteins assessment as prognostic and predictive biomarkers in the EGF30008 clinical trial

P Nuciforo, S Thyparambil, P Galván, M Vilaro, J Jimenez, W-L Liao, F Cecchi, A Blackler, MF Press, R Gagnon, C Ellis, T Hembrough, S Johnston, A Prat
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P3-07-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P3-07-08
Published: 15 February 2016
View article
Journal Articles

Abstract P1-13-03: Genome wide association study (GWAS) of genetic variants associated with docetaxel toxicity in the ROSE/TRIO-012 trial

S Damaraju, V Gorbunova, K Gelmon, J García-Saenz, S Morales-Murillo, D AbiGerges, J-L Canon, I Kiselev, GL Cohen, G Jerusalem, F Thireau, R Fresco, V Houé, MF Press, M Kumaran, JR Mackey
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P1-13-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P1-13-03
Published: 15 February 2016
View article
Journal Articles

Abstract P6-14-03: Genome wide association study (GWAS) to identify variants conferring ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial

JR Mackey, O Lipatov, M Martín, M Webster, R Hegg, S Verma, M Ramos-Vázquez, R Fresco, F Thireau, V Houé, MF Press, M Kumaran, S Damaraju
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P6-14-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P6-14-03
Published: 15 February 2016
View article
Journal Articles

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

DJ Slamon, W Eiermann, NJ Robert, J Giermek, M Martin, M Jasiowka, JR Mackey, A Chan, M-C Liu, T Pinter, V Valero, C Falkson, T Fornander, TA Shiftan, S Bensfia, S Hitier, N Xu, V Bée-Munteanu, P Drevot, MF Press, J Crown, On Behalf of the BCIRG-006 Investigators
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): S5-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-S5-04
Published: 15 February 2016
View article
Journal Articles

Abstract S1-03: Primary results from BETH, a phase 3 controlled study of adjuvant chemotherapy and trastuzumab ± bevacizumab in patients with HER2-positive, node-positive or high risk node-negative breast cancer

DJ Slamon, SM Swain, M Buyse, M Martin, CE Geyer, Y-H Im, T Pienkowski, S-B Kim, NJ Robert, G Steger, J Crown, S Verma, W Eiermann, JP Costantino, S-A Im, EP Mamounas, L Schwartzberg, A Paterson, JR Mackey, L Provencher, MF Press, M Thirlwell, V Bee-Munteanu, V Henschel, A Crepelle-Flechais, N Wolmark
Journal: Cancer Research
Cancer Res (2013) 73 (24_Supplement): S1-03.
DOI: https://doi.org/10.1158/0008-5472.SABCS13-S1-03
Published: 15 December 2013
View article
Journal Articles

Abstract P4-08-05: Basement membrane localized tumor cells are protected from HER2-targeted therapy in vivo.

JJ Zoeller, RT Bronson, TM Gilmer, LM Selfors, Y Lu, SK Apple, MF Press, SA Hurvitz, DJ Slamon, GB Mills, JS Brugge
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): P4-08-05.
DOI: https://doi.org/10.1158/0008-5472.SABCS12-P4-08-05
Published: 15 December 2012
View article
Journal Articles

Abstract PD10-02: Round-Robin Review of HER2 Testing in the Context of Adjuvant Therapy for Breast Cancer (NCCTG N9831/BCIRG006/BCIRG005)

EA Perez, AC Dueck, MF Press, B Chen, RB Jenkins, S Paik, C Kim, AE Wiktor, RG Meyer, RP Ketterling, I Villalobos, M Finnigan, M Buyse, J Zujewski, M Shing, H Stern, WL Lingle, MM Reinholz, DJ. Slamon
Journal: Cancer Research
Cancer Res (2010) 70 (24_Supplement): PD10-02.
DOI: https://doi.org/10.1158/0008-5472.SABCS10-PD10-02
Published: 15 December 2010
View article
Journal Articles

HER2/ER subtypes associated with patient and tumor factors and predicted survival among participants in a retrospective breast cancer cohort study in Southern California.

R Haque, MF Press, JA Polikoff, CC Avila, SM Enger
Journal: Cancer Research
Cancer Res (2009) 69 (2_Supplement): 3099.
DOI: https://doi.org/10.1158/0008-5472.SABCS-3099
Published: 15 January 2009
View article
Journal Articles

Baseline serum extracellular domain HER2 expression in hormone receptor-positive metastatic breast cancer: correlation with known tissue HER2 status.

S Johnston, L O'Rouke, W Wang, M Pegram, MF Press, J Maltzman
Journal: Cancer Research
Cancer Res (2009) 69 (2_Supplement): 3147.
DOI: https://doi.org/10.1158/0008-5472.SABCS-3147
Published: 15 January 2009
View article
Journal Articles

Correlation of tumor burden, liver and bone metastasis with serum extracellular domain HER2 expression in front-line metastatic breast cancer.

S Johnston, L O'Rourke, W Wang, M Pegram, MF Press, J Maltzman
Journal: Cancer Research
Cancer Res (2009) 69 (2_Supplement): 3146.
DOI: https://doi.org/10.1158/0008-5472.SABCS-3146
Published: 15 January 2009
View article